Shanghai RAAS Blood Products Co., Ltd. (Stock Code: 002252) recently released its Q1 2024 financial report. As a leading enterprise in the blood products industry, the report has attracted the attention of many investors. Next, we will conduct an in-depth analysis of this report from various aspects such as asset and liability data, profit data, and cash flow data.

First, let's look at the asset and liability data. The report shows that the balance of total assets of the company at the end of the period was CNY 32.777 billion, which increased by 2.66% compared to the beginning of the period, indicating the company's continuous expansion. At the same time, the equity attributable to shareholders of the listed company also recorded an increase of 2.73%, reflecting the steady increase of the company's net assets. It is worth noting that the company's asset-liability ratio decreased from 7.14% at the beginning of the period to 7.07%, indicating that the company is optimizing its capital structure while expanding its scale and reducing financial risks.

In terms of profit data, Shanghai RAAS's net income attributable to shareholders of the listed company increased by 5.32% year-on-year to CNY 0.757 billion in the first quarter. Despite facing challenges such as intensified industry competition, the company still maintains a steady growth of profitability, which is not easy. In addition, the net margin of the company increased from 34.82% in the same period of the previous year to 36.82%, mainly due to the improvement of the company's refined management and cost control capabilities. However, the decline in gross margin is also worth noting, which may mean that the company's product costs have increased or market competition has intensified, posing certain pressure on future profitability.

Moving on to the cash flow data, the net cash flow from operating activities decreased by 29.86% year-on-year, mainly due to the decrease in receivables received during the reporting period compared to the same period of the previous year, while payments for payables and taxes have increased. However, the net cash flow from investing activities of the company has achieved a significant growth, mainly due to the disposal of trading financial assets in the current period, which has brought considerable inflow of cash to the company. On the other hand, the net cash flow from financing activities is negative, and its absolute value has increased compared to the same period of the previous year, which reflects the increase in the company's expenditures for repaying debt and interest, but it also helps optimize the company's debt structure.

In summary, the Q1 report of Shanghai RAAS presents a situation of stability with changes. The company is actively responding to industry changes and market challenges while maintaining steady development. Although some financial indicators have fluctuated, overall, the company's operating conditions remain stable, and its future development potential is promising. Investors should pay close attention to the company's subsequent dynamics in order to make wiser investment decisions.